PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China flag China · Delayed Price · Currency is CNY
46.36
-0.89 (-1.88%)
Jan 21, 2026, 4:00 PM EST
91.25%
Market Cap6.37B
Revenue (ttm)667.47M
Net Income (ttm)36.59M
Shares Out137.54M
EPS (ttm)0.26
PE Ratio181.01
Forward PE140.30
Dividend0.50 (1.08%)
Ex-Dividend DateNov 14, 2025
Volume13,118,505
Average Volume11,854,604
Open45.92
Previous Close47.25
Day's Range45.00 - 48.30
52-Week Range22.21 - 67.97
Beta0.89
RSI58.23
Earnings DateApr 29, 2026

About SHE:301230

PharmaResources (Shanghai) Co., Ltd. engages in new drug research, development, and commercial production in China. It offers small molecule drug CRO, CDMO, and CMO. The company also involved in drug discovery, research, and development of pharmaceutical processes; and customized and commercial production of APIs, and key intermediates. It serves global pharmaceutical and biotechnology companies. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 1,085
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301230
Full Company Profile

Financial Performance

In 2024, SHE:301230's revenue was 544.47 million, an increase of 11.18% compared to the previous year's 489.72 million. Earnings were 17.08 million, a decrease of -54.59%.

Financial Statements